TIFFANY SARIC: Open Payments
NPI 1265003180 · MOUNTAIN HOME, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $80 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $53 |
| Amgen Inc. | 1 | $35 |
| Currax Pharmaceuticals LLC | 2 | $32 |
| Organon LLC | 1 | $26 |
| Exeltis, USA Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: SPRAVATO, Wegovy, EVENITY, NEXPLANON, SLYND, ZURZUVAE, ImmunoCAP, ONZETRA XSAIL.
Industry payments across AR — which companies pay providers there.
